Gastrointestinal bleeding on continuous-flow left ventricular assist device therapy
- PMID: 37322822
- PMCID: PMC10375148
- DOI: 10.1002/ehf2.14433
Gastrointestinal bleeding on continuous-flow left ventricular assist device therapy
Abstract
While technological advances in the field of continuous-flow left ventricular assist device (CF-LVAD) are constantly being made, CF-LVAD recipients are still subjected to a relatively high rate of LVAD-related adverse events, with post-LVAD gastrointestinal bleeding (GIB) being the most common one. GIB is associated with a significant impairment in quality of life, multiple hospital admissions, blood transfusion requirements and possibly death. Furthermore, of those patients who bled once, many will experience recurrent GIB events, which further aggravates their discomfort. While some medical and endoscopic treatment options are available, evidence regarding their benefit remains largely equivocal, with all related studies based on data from registries rather than clinical trials. Although having a major impact on LVAD recipients, an effective and validated pre-implant screening options to predict GIB events post-implant are scarce. This review focuses on the aetiology, incidence, risk factors, treatment options and the effect of new generation devices on post-LVAD GIB.
Keywords: Arteriovenous malformations; Continuous-flow left ventricular assist device; Gastrointestinal bleeding; Heartmate 3.
© 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Conflict of interest statement
None declared.
Figures
References
-
- Kormos RL, Cowger J, Pagani FD, Teuteberg JJ, Goldstein DJ, Jacobs JP, Higgins RS, Stevenson LW, Stehlik J, Atluri P, Grady KL, Kirklin JK. The Society of Thoracic Surgeons Intermacs Database Annual Report: evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 2019; 38: 114–126. - PubMed
-
- Yuzefpolskaya M, Schroeder SE, Houston BA, Robinson MR, Gosev I, Reyentovich A, Koehl D, Cantor R, Jorde UP, Kirklin JK, Pagani FD, D’Alessandro DA. The Society of Thoracic Surgeons Intermacs 2022 Annual Report: focus on the 2018 Heart Transplant Allocation System. Ann Thorac Surg. 2023; 115: 311–327. - PubMed
-
- Mehra MR, Uriel N, Naka Y, Cleveland JC Jr, Yuzefpolskaya M, Salerno CT, Walsh MN, Milano CA, Patel CB, Hutchins SW, Ransom J, Ewald GA, Itoh A, Raval NY, Silvestry SC, Cogswell R, John R, Bhimaraj A, Bruckner BA, Lowes BD, Um JY, Jeevanandam V, Sayer G, Mangi AA, Molina EJ, Sheikh F, Aaronson K, Pagani FD, Cotts WG, Tatooles AJ, Babu A, Chomsky D, Katz JN, Tessmann PB, Dean D, Krishnamoorthy A, Chuang J, Topuria I, Sood P, Goldstein DJ, MOMENTUM 3 Investigators . A fully magnetically levitated left ventricular assist device ‐ final report. N Engl J Med. 2019; 380: 1618–1627. - PubMed
-
- Mehra MR, Crandall DL, Gustafsson F, Jorde UP, Katz JN, Netuka I, Uriel N, Connors JM, Sood P, Heatley G, Pagani FD. Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo‐controlled, non‐inferiority ARIES HM3 trial. Eur J Heart Fail. 2021; 23: 1226–1237. - PMC - PubMed
-
- Kataria R, Jorde UP. Gastrointestinal bleeding during continuous‐flow left ventricular assist device support: state of the field. Cardiol Rev. 2019; 27: 8–13. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
